Development and validation of <sup>68</sup>Ga-PSMA-11 PET/CT-based radiomics model to detect primary prostate cancer.

Authors:
Zang S; Ai S; Yang R; Zhang P; Wu W and 7 more

Journal:
EJNMMI Res

Publication Year: 2022

DOI:
10.1186/s13550-022-00936-5

PMCID:
PMC9522942

PMID:
36175753

View on PubMed View on PMC View Publisher
Journal Information

Full Title: EJNMMI Res

Abbreviation: EJNMMI Res

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Radiology, Nuclear Medicine & Medical Imaging

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Dynamic whole-body [<sup>18</sup>F]FES PET/CT increases lesion visibility in patients with metastat…
Pedersen MA; Munk OL; Dias AH and 11 more (2024) - Transparency Score: 4/6
Pharmacodynamics and biodistribution of [195mPt]cisplatin(CISSPECT®) in head and neck squamous cell…
de Roest RH; Stigter van Walsum M; van der Schilden K and 1 more (2024) - Transparency Score: 3/6
PSMA imaging as a non-invasive tool to monitor inducible gene expression in vivo.
Simunic M; Joshi JT; Merkens H and 4 more (2024) - Transparency Score: 3/6
Risk of treatment-altering haematological toxicity and its dependence on bone marrow doses in pepti…
Persson M; Hindorf C; Ardenfors O and 2 more (2024) - Transparency Score: 3/6
Spherization indices measured by resting SPECT improve risk stratification in patients with ischemi…
Zhao Y; Hu Y; Li Y and 9 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateThis work has been performed in accordance with the Declaration of Helsinki and approved by the Ethics Committee of Nanjing First Hospital. Due to the retrospective study design, obtaining informed consent was waived for the included patients. Consent for publicationInformed consent was obtained from all individual participants included in the study. Competing interestsThe authors declare that they have no competing interests. Competing interests The authors declare that they have no competing interests."

Evidence found in paper:

"Funding This study has received funding from Natural Science Foundation of Jiangsu Province (BE2021605)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025